119-s2285

S
✓ Complete Data

Uterine Cancer Study Act of 2025

Login to track bills
Introduced:
Jul 15, 2025
Policy Area:
Health

Bill Statistics

2
Actions
2
Cosponsors
0
Summaries
1
Subjects
1
Text Versions
Yes
Full Text

AI Summary

No AI Summary Available

Click the button above to generate an AI-powered summary of this bill using Claude.

The summary will analyze the bill's key provisions, impact, and implementation details.

Latest Action

Jul 15, 2025
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Actions (2)

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Type: IntroReferral | Source: Senate
Jul 15, 2025
Introduced in Senate
Type: IntroReferral | Source: Library of Congress | Code: 10000
Jul 15, 2025

Subjects (1)

Health (Policy Area)

Cosponsors (2)

Text Versions (1)

Introduced in Senate

Jul 15, 2025

Full Bill Text

Length: 3,272 characters Version: Introduced in Senate Version Date: Jul 15, 2025 Last Updated: Nov 15, 2025 2:15 AM
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. 2285 Introduced in Senate

(IS) ]

<DOC>

119th CONGRESS
1st Session
S. 2285

To direct the Secretary of Health and Human Services to study and
report on the relationship between hair straighteners and uterine
cancer, particularly among women of color.

_______________________________________________________________________

IN THE SENATE OF THE UNITED STATES

July 15, 2025

Ms. Blunt Rochester introduced the following bill; which was read twice
and referred to the Committee on Health, Education, Labor, and Pensions

_______________________________________________________________________

A BILL

To direct the Secretary of Health and Human Services to study and
report on the relationship between hair straighteners and uterine
cancer, particularly among women of color.

Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1.

This Act may be cited as the ``Uterine Cancer Study Act of 2025''.
SEC. 2.
CANCER.

(a) Study.--The Secretary, in coordination with the Commissioner of
Food and Drugs and the Director of the National Institutes of Health,
shall conduct a study on the relationship between hair straighteners
and uterine cancer, with a focus on the increased incidence of such
cancer among women of color. Such study shall--

(1) review significant findings and recommendations from
other studies regarding the relationship between hair
straighteners and uterine cancer;

(2) consider impacts on women and other individuals at risk
of uterine cancer from all racial and ethnic backgrounds;

(3) disaggregate the results of the study under this
section according to whether the hair straighteners contain
dyes or coloring, bleach, highlights, or perms; and

(4) determine whether the Food and Drug Administration
should impose additional testing requirements on the
manufacturers of hair straightening products to ensure the
safety of such products.

(b) Methodology.--Not later than 45 days after the date of
enactment of this Act, the Secretary shall submit to the Committee on
Health, Education, Labor, and Pensions of the Senate and the Committee
on Energy and Commerce of the House of Representatives a description of
the methodology that will be used to conduct the study under this
section.
(c) Commencement.--Not later than 180 days after the date of
enactment of this Act, the Secretary shall commence the study under
this section.
(d) Report.--Not later than 2 years after the date of enactment of
this Act, the Secretary shall complete the study under this section and
submit to the Committee on Health, Education, Labor, and Pensions of
the Senate and the Committee on Energy and Commerce of the House of
Representatives a report on the results of such study.

(e)
=== Definition. === -In this section: (1) Hair straightener.--The term ``hair straightener'' means a chemical hair straightener. (2) Secretary.--The term ``Secretary'' means the Secretary of Health and Human Services. <all>